Evidence map›Paper›PMID 19846511›Full record

ArticleJournal of virology2010

Human cytomegalovirus induces the interferon response via the DNA sensor ZBP1.

Victor R DeFilippis, David Alvarado, Tina Sali, Stefan Rothenburg, Klaus Früh

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 121 papers.

0numbers the graph read from it
0cells of the map it votes in
121citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

121 citing papers in PubMed, 198 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. The Z-nucleic acid sensor ZBP1 in health and disease.The Journal of experimental medicine · 2023
    Article
  12. Article
  13. Z-DNA and Z-RNA: Methods-Past and Future.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  14. ZBP1 and heatstroke.Frontiers in immunology · 2023
    Review
  15. Programmed Necrosis in Host Defense.Current topics in microbiology and immunology · 2023
    Article
  16. Review
  17. Article
  18. Review
  19. In vitro and in vivo correlation of skin and cellular responses to nucleic acid delivery.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022
    Article
  20. Article

61 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Victor R DeFilippisOregon Health and Science University, Vaccine and Gene Therapy Institute, Beaverton, OR 97006, USA. defilipp@ohsu.edu
David Alvarado
Tina Sali
Stefan Rothenburg
Klaus Früh
Oregon Health & Science University · USEunice Kennedy Shriver National Institute of Child Health and Human Development · US

Funding

YR 50 PROJ- ROBERTS PRIMATE ISLETP51RR000163 · NCRR · OREGON REGIONAL PRIMATE RESEARCH CENTER · PI OJEDA, SERGIO R · 1985 to 2011
$140.8M
Evasion of Antigen Presentation by Rhesus CytomegalovirusR01AI059457 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI FRUH, KLAUS J · 2005 to 2021
$6.2M
Modulation of Innate Immune Responses by CytomegalovirusR01AI070890 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI FRUH, KLAUS J · 2008 to 2012
$2.4M
NCRR NIH HHS P51 RR000163NIAID NIH HHS R01 AI059457NIAID NIH HHS R01 AI070890NIAID NIH HHS R01AI070890
6 · The paper itself

Abstract

Human cytomegalovirus (HCMV) is a member of the betaherpesvirus family that, unlike other herpesviruses, triggers a strong innate immune response in infected cells that includes transcription of the beta interferon gene via activation of interferon regulatory factor 3 (IRF3). IRF3 activation requires signaling from pattern recognition receptors that is initiated by their interaction with specific pathogen-associated molecules. However, while IRF3-activating pathways are increasingly well characterized, the cellular molecules involved in HCMV-mediated IRF3-dependent beta interferon transcription are virtually unknown. We undertook a systematic examination of new and established IRF3-terminal pathway components to identify those that are essential to HCMV-triggered IRF3 activation. We show here that IRF3 activation induced by HCMV infection involves the newly identified protein STING but, in contrast to infections with other herpesviruses, occurs independently of the adaptor molecule IPS-1. We also show that the protein DDX3 contributes to HCMV-triggered expression of beta interferon. Moreover, we identify Z-DNA binding protein 1 (ZBP1) as being essential for IRF3 activation and interferon beta expression triggered by HCMV, as well as being sufficient to enhance HCMV-stimulated beta interferon transcription and secretion. ZBP1 transcription was also found to be induced following exposure to HCMV in a JAK/STAT-dependent manner, thus perhaps also contributing to a positive feedback signal. Finally, we show that constitutive overexpression of ZBP1 inhibits HCMV replication. ZBP1 was recently identified as a cytosolic pattern recognition receptor of double-stranded DNA, and thus, we propose a model for HCMV-mediated IRF3 activation that involves HCMV-associated DNA as the principal innate immune-activating pathogen-associated molecular pattern.

Indexed as

Cells, CulturedCytomegalovirusDEAD-box RNA HelicasesDNADNA-Binding ProteinsFibroblastsHumansImmunity, InnateInterferon-betaInterferon Regulatory Factor-3Membrane ProteinsRNA-Binding ProteinsSTING ProteinTranscriptional ActivationTranscription, GeneticDDX3X protein, humanDEAD-box RNA HelicasesDNADNA-Binding ProteinsInterferon-betaInterferon Regulatory Factor-3IRF3 protein, humanMembrane ProteinsRNA-Binding ProteinsSTING1 protein, humanSTING ProteinZBP1 protein, human

Identifiers

PMID19846511
PMCPMC2798427
OpenAlexW2127684626

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.